Search - tctmd.com

Displaying 241 - 260 of 1041

Sort: Relevancy | Date

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

CASSISS: No Benefit of Stenting for Intracranial Stenosis

Todd Neale

August 12, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Daily News

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Caitlin E. Cox

August 04, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Michael O'Riordan

July 06, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Opinion Off Script

To Save a Dying Mother

Kathryn J. Lindley, MD

June 28, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

Advertisement

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Polypill Bests Usual Care in Patients With Recent MI: SECURE

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

What’s Going to Be Hot at ESC 2022?

Worse Complications After PVI in Women Highlight Research Gaps

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

CASSISS: No Benefit of Stenting for Intracranial Stenosis

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

High Lp(a) May Predict Risk of CV and Limb Events in PAD

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

To Save a Dying Mother

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content